- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04336306
Virtual Reality-based Therapy and Barriers in Cardiac Patients
July 19, 2023 updated by: Mayara Moura Alves da Cruz, Universidade Estadual Paulista Júlio de Mesquita Filho
Cardiovascular Rehabilitation: Insertion of Virtual Reality-based Therapy and Evaluation of Barriers
The aim of this study is to investigate the chronic hemodynamic and autonomic repercussions of the insertion of VRBT in CR.
To qualitatively analyze the perception of patients and physiotherapists regarding the use of VRBT, as well as their association with CR, and through a new questionnaire that takes into account patients 'adherence, identifying which are the main barriers that influence patients' absences.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Introduction: Despite the benefits that cardiovascular rehabilitation programs (CR) can promote, there are problems regarding adherence, which can be related to several factors, among them, motivation.
Alternative therapies can reflect on motivation and promote increased adherence to CR.
In this context, virtual reality-based therapy (VRBT) appears as an option.
Additionally, chronic hemodynamic and autonomic repercussions of VRBT in relation to CV still need to be investigated.
Objective: To evaluate the chronic hemodynamic and autonomic repercussions of the insertion of VRBT in CR.
To qualitatively analyze the perception of patients and physiotherapists regarding the use of TRV, as well as their association with CR, and through a new questionnaire that takes into account patients 'adherence, identifying which are the main barriers that influence patients' absences.
Methods: cardiac patients or individuals with factors that regularly participate in CR will participate in this study.
Patients will be randomly allocated to CR + VRBT intervention or keeping the normal routine.
Interventions will be carried out three times a week for 12 weeks.
The primary outcome will be to assess chronic hemodynamic repercussions (blood pressure, heart rate, respiratory rate, oxygen saturation and perceived exertion using the Borg scale) and autonomic (linear and non-linear data).
The secondary outcome consists of a qualitative assessment through a focus group with patients and a focus group with therapists, in addition, the new questionnaire developed to identify the influence of barriers on patients' adherence to CR will be applied.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mayara MA da Cruz, Master
- Phone Number: +55(18)997831661
- Email: maya_bilac@hotmail.com
Study Locations
-
-
São Paulo
-
Presidente Prudente, São Paulo, Brazil, 19060-900
- Universidade Estadual Paulista Júlio de Mesquita Filho
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Clinical diagnosis of cardiovascular disease.
- Clinical diagnosis of cardiovascular risk factors.
Exclusion Criteria:
- Presence exacerbated signs or symptoms.
- Balance problems.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Evaluation of chronic hemodynamic and autonomic repercussions
Participants in a cardiovascular rehabilitation program will be randomly allocated to CR + VRBT interventions.
This group will hold 3 weekly sessions (one for VRBT and two for CR) for 12 weeks.
In the first, sixth and last week, chronic hemodynamic data and autonomic data will be evaluated.Furthermore,at the end of 12 weeks, a focus group with therapists and a focus group with patients will be held to identify qualitative aspects in relation to the insertion of VRBT.
And in all eligible patients of CR wiil be applied the Questionnaire of barriers identification in frequenters of Cardiovascular Rehabilitation.
|
The warm-up was performed using the "Just Dance 2015" game, in a sequence previously defined in a pilot study, aiming to increase HR progressively.
A multimedia projector (Epson Power Life, H309A, China) connected to a console (Xbox One KinectTM, Microsoft, Redmond, WA) was used to project the game onto a white wall.The conditioning phase was performed using the "Shape Up" exercise game, in which patients perform exercises following a virtual therapist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chronic autonomic response: linear indices
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using heart rate variability : SDNN: the standard deviation of normal-to-normal intervals, ms; rMSSD: the root mean square of successive difference between normal intervals,ms; RRtri: triangular index, based on RR intervals,ms; TINN: triangular interpolation of the normal to normal interval between consecutive heart beats, ms; LF: low frequency, nu; HF: high frequency.
In general higher values represent a better autonomic response.
|
Change from baseline at 6 and 12 weeks
|
Chronic autonomic response:no linear indices
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using heart rate variability : Detrended Fluctuation Analysis, Recurrence Plot, Multiscalar Entropy, symbolic analysis.In general higher values represent a better autonomic response.
|
Change from baseline at 6 and 12 weeks
|
Blood pressure
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using both systolic blood pressure and diastolic blood pressure
|
Change from baseline at 6 and 12 weeks
|
Heart rate
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using an equipment validated for recording heart rate beat to beat
|
Change from baseline at 6 and 12 weeks
|
Respiratory rate
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using the number of respiratory incursions in one minute
|
Change from baseline at 6 and 12 weeks
|
Oxygen Saturation
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using an oximeter
|
Change from baseline at 6 and 12 weeks
|
Perceived Exertion
Time Frame: Change from baseline at 6 and 12 weeks
|
Measured using Borg Scale, this scale varies from 6 to 20
|
Change from baseline at 6 and 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perception of physiotherapists about the barriers and facilitators of the use of Virtual reality
Time Frame: After 12 weeks
|
Measured by a focal groups with 5 therapist, that used virtual reality.
Focal groups will be conducted by a researcher using a previously developed script, with open questions.
The moderator will be a PhD student, with previous experience in physical training and qualitative research.
A second researcher will be present at the focal groups to detail notes of the participant's answers.
|
After 12 weeks
|
Perception of patients about Virtual reality
Time Frame: After 12 weeks
|
Measured by a 3 focal groups with 4 to 8 patients each, that performed virtual reality.
Focal groups will be conducted by a researcher using a previously developed script, with open questions.
The moderator will be a PhD student, with previous experience in physical training and qualitative research.
A second researcher will be present at the focal groups to detail notes of the participant's answers.
|
After 12 weeks
|
Barriers identification in frequenters of Cardiovascular Rehabilitation.
Time Frame: After 12 week
|
Measured by a new questionnaire of barriers.
This new questionnaire has 15 questions, which are divided into domains.
|
After 12 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mayara MA da Cruz, Master, Universidade Estadual Paulista Júlio de Mesquita Filho
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Alves da Cruz MM, Ricci-Vitor AL, Bonini Borges GL, Fernanda da Silva P, Ribeiro F, Marques Vanderlei LC. Acute Hemodynamic Effects of Virtual Reality-Based Therapy in Patients of Cardiovascular Rehabilitation: A Cluster Randomized Crossover Trial. Arch Phys Med Rehabil. 2020 Apr;101(4):642-649. doi: 10.1016/j.apmr.2019.12.006. Epub 2020 Jan 8.
- da Cruz MMA, Ricci-Vitor AL, Borges GLB, da Silva PF, Turri-Silva N, Takahashi C, Grace SL, Vanderlei LCM. A Randomized, Controlled, Crossover Trial of Virtual Reality in Maintenance Cardiovascular Rehabilitation in a Low-Resource Setting: Impact on Adherence, Motivation, and Engagement. Phys Ther. 2021 May 4;101(5):pzab071. doi: 10.1093/ptj/pzab071.
- da Cruz MMA, Grigoletto I, Ricci-Vitor AL, da Silva JM, Franco MR, Vanderlei LCM. Perceptions and preferences of patients with cardiac conditions to the inclusion of virtual reality-based therapy with conventional cardiovascular rehabilitation: A qualitative study. Braz J Phys Ther. 2022 May-Jun;26(3):100419. doi: 10.1016/j.bjpt.2022.100419. Epub 2022 May 18.
- Alves da Cruz M, Laurino M, Christofaro D, Ghisi G, Vanderlei L. Long-term effects of virtual reality-based therapy in cardiovascular rehabilitation: A longitudinal study. Physiother Theory Pract. 2022 Dec 25:1-9. doi: 10.1080/09593985.2022.2160222. Online ahead of print.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2020
Primary Completion (Actual)
June 30, 2020
Study Completion (Actual)
October 23, 2022
Study Registration Dates
First Submitted
March 31, 2020
First Submitted That Met QC Criteria
April 6, 2020
First Posted (Actual)
April 7, 2020
Study Record Updates
Last Update Posted (Actual)
July 21, 2023
Last Update Submitted That Met QC Criteria
July 19, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 29742920.9.0000.5402
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on virtual reality-based therapy (VRBT)
-
Abant Izzet Baysal UniversityRecruitingStroke | Upper Extremity Paralysis | Upper Extremity ParesisTurkey
-
Drexel UniversityCompletedPhysical Activity | Cognitive Decline | Psychological WellbeingUnited States
-
Universitat Pompeu FabraUnknownPatients With Unilateral Peripheral Vestibular DeficitsSpain
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Older Adults | Neurological InjuryUnited States
-
Abant Izzet Baysal UniversityCompleted
-
Chang Gung Memorial HospitalNot yet recruitingStroke | Cerebrovascular Disorders | Central Nervous System DiseasesTaiwan
-
University of Michigan Rogel Cancer CenterNRG OncologyCompletedCancer-related Cognitive Impairment | Breast Cancer SurvivorshipUnited States
-
Qassim UniversityCairo University; Prince Sattam Bin Abdulaziz UniversityCompletedChildren | Congenital Diaphragmatic Hernia | Virtual RealitySaudi Arabia
-
Sheba Medical CenterEuropean CommissionCompleted
-
Umm Al-Qura UniversityCompletedUpper Extremity Dysfunction | Spastic Hemiplegia | Spasticity as Sequela of StrokeSaudi Arabia